To evaluate the effect of ADAR1 downregulation on the acquisition of invasive potential, four melanoma cell lines (624mel, 003mel, A375, and WM-266-4) were stably transduced with ADAR1-shRNA (knockdown, KD) or non-targeted-shRNA (control), as previously described27. The gene discussed is ADAR; the disease is melanoma.